Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dopamine D3 receptor antagonists having a morpholine moiety

Dopamine D3 receptor antagonists having a morpholine moiety

US Patent 10577361 · Granted Mar 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small-molecule PI5P4K alpha/beta inhibitors and methods of treatment using same2023
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives2023
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives2023
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives2023
Dopamine D3 receptor antagonist compounds2020
Dopamine D3 receptor antagonist compounds2020
Dopamine D3 receptor antagonist compounds2020
Substituted 3,6-diazabicyclo[3.2.0]heptanes2020
Substituted 3,6-diazabicyclo[3.2.0]heptanes2020
Substituted 3,6-diazabicyclo[3.2.0]heptanes2020
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles a2019
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles a2019